51
|
Deal HE, Brown AC, Daniele MA. Microphysiological systems for the modeling of wound healing and evaluation of pro-healing therapies. J Mater Chem B 2020; 8:7062-7075. [PMID: 32756718 PMCID: PMC7460719 DOI: 10.1039/d0tb00544d] [Citation(s) in RCA: 11] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]
Abstract
Wound healing is a multivariate process involving the coordinated response of numerous proteins and cell types. Accordingly, biomedical research has seen an increased adoption of the use of in vitro wound healing assays with complexity beyond that offered by traditional well-plate constructs. These microphysiological systems (MPS) seek to recapitulate one or more physiological features of the in vivo microenvironment, while retaining the analytical capacity of more reductionist assays. Design efforts to achieve relevant wound healing physiology include the use of dynamic perfusion over static culture, the incorporation of multiple cell types, the arrangement of cells in three dimensions, the addition of biomechanically and biochemically relevant hydrogels, and combinations thereof. This review provides a brief overview of the wound healing process and in vivo assays, and we critically review the current state of MPS and supporting technologies for modelling and studying wound healing. We distinguish between MPS that seek to inform a particular phase of wound healing, and constructs that have the potential to inform multiple phases of wound healing. This distinction is a product of whether analysis of a particular process is prioritized, or a particular physiology is prioritized, during design. Material selection is emphasized throughout, and relevant fabrication techniques discussed.
Collapse
Affiliation(s)
- Halston E Deal
- Joint Department of Biomedical Engineering, North Carolina State University and University of North Carolina, Chapel Hill, 911 Oval Dr., Raleigh, NC 27695, USA. and Comparative Medicine Institute, North Carolina State University, 1060 William Moore Dr., Raleigh, NC 27606, USA
| | - Ashley C Brown
- Joint Department of Biomedical Engineering, North Carolina State University and University of North Carolina, Chapel Hill, 911 Oval Dr., Raleigh, NC 27695, USA. and Comparative Medicine Institute, North Carolina State University, 1060 William Moore Dr., Raleigh, NC 27606, USA
| | - Michael A Daniele
- Joint Department of Biomedical Engineering, North Carolina State University and University of North Carolina, Chapel Hill, 911 Oval Dr., Raleigh, NC 27695, USA. and Comparative Medicine Institute, North Carolina State University, 1060 William Moore Dr., Raleigh, NC 27606, USA and Department of Electrical & Computer Engineering, North Carolina State University, 890 Oval Dr., Raleigh, NC 27695, USA
| |
Collapse
|
52
|
Cui X, Li J, Hartanto Y, Durham M, Tang J, Zhang H, Hooper G, Lim K, Woodfield T. Advances in Extrusion 3D Bioprinting: A Focus on Multicomponent Hydrogel-Based Bioinks. Adv Healthc Mater 2020; 9:e1901648. [PMID: 32352649 DOI: 10.1002/adhm.201901648] [Citation(s) in RCA: 126] [Impact Index Per Article: 31.5] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/18/2019] [Revised: 02/14/2020] [Accepted: 03/17/2020] [Indexed: 12/18/2022]
Abstract
3D bioprinting involves the combination of 3D printing technologies with cells, growth factors and biomaterials, and has been considered as one of the most advanced tools for tissue engineering and regenerative medicine (TERM). However, despite multiple breakthroughs, it is evident that numerous challenges need to be overcome before 3D bioprinting will eventually become a clinical solution for a variety of TERM applications. To produce a 3D structure that is biologically functional, cell-laden bioinks must be optimized to meet certain key characteristics including rheological properties, physico-mechanical properties, and biofunctionality; a difficult task for a single component bioink especially for extrusion based bioprinting. As such, more recent research has been centred on multicomponent bioinks consisting of a combination of two or more biomaterials to improve printability, shape fidelity and biofunctionality. In this article, multicomponent hydrogel-based bioink systems are systemically reviewed based on the inherent nature of the bioink (natural or synthetic hydrogels), including the most current examples demonstrating properties and advances in application of multicomponent bioinks, specifically for extrusion based 3D bioprinting. This review article will assist researchers in the field in identifying the most suitable bioink based on their requirements, as well as pinpointing current unmet challenges in the field.
Collapse
Affiliation(s)
- Xiaolin Cui
- Christchurch Regenerative Medicine and Tissue Engineering (CReaTE) Group, Department of Orthopaedic Surgery and Musculoskeletal Medicine, University of Otago, Christchurch, 8011, New Zealand
- Medical Technologies Centre of Research Excellence, Auckland, 1142, New Zealand
| | - Jun Li
- Christchurch Regenerative Medicine and Tissue Engineering (CReaTE) Group, Department of Orthopaedic Surgery and Musculoskeletal Medicine, University of Otago, Christchurch, 8011, New Zealand
| | - Yusak Hartanto
- Department of Chemical Engineering, University of Adelaide, Adelaide, SA, 5005, Australia
| | - Mitchell Durham
- Christchurch Regenerative Medicine and Tissue Engineering (CReaTE) Group, Department of Orthopaedic Surgery and Musculoskeletal Medicine, University of Otago, Christchurch, 8011, New Zealand
| | - Junnan Tang
- Department of Cardiology, First Affiliated Hospital of Zhengzhou University, Zhengzhou, 450000, China
| | - Hu Zhang
- Henry E. Riggs School of Applied Life Sciences, Keck Graduate Institute, Claremont, CA, 91711, USA
| | - Gary Hooper
- Christchurch Regenerative Medicine and Tissue Engineering (CReaTE) Group, Department of Orthopaedic Surgery and Musculoskeletal Medicine, University of Otago, Christchurch, 8011, New Zealand
- Medical Technologies Centre of Research Excellence, Auckland, 1142, New Zealand
| | - Khoon Lim
- Christchurch Regenerative Medicine and Tissue Engineering (CReaTE) Group, Department of Orthopaedic Surgery and Musculoskeletal Medicine, University of Otago, Christchurch, 8011, New Zealand
- Medical Technologies Centre of Research Excellence, Auckland, 1142, New Zealand
- Maurice Wilkins Centre for Molecular Biodiscovery, Auckland, 1142, New Zealand
| | - Tim Woodfield
- Christchurch Regenerative Medicine and Tissue Engineering (CReaTE) Group, Department of Orthopaedic Surgery and Musculoskeletal Medicine, University of Otago, Christchurch, 8011, New Zealand
- Medical Technologies Centre of Research Excellence, Auckland, 1142, New Zealand
- Maurice Wilkins Centre for Molecular Biodiscovery, Auckland, 1142, New Zealand
| |
Collapse
|
53
|
Åstrand C, Chotteau V, Falk A, Hedhammar M. Assembly of FN-silk with laminin-521 to integrate hPSCs into a three-dimensional culture for neural differentiation. Biomater Sci 2020; 8:2514-2525. [PMID: 32215392 DOI: 10.1039/c9bm01624d] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
Three-dimensional (3D) neural tissue cultures recapitulate the basic concepts during development and disease better than what can be obtained using conventional two-dimensional cultures. Here, we use a recombinant spider silk protein functionalized with a cell binding motif from fibronectin (FN-silk) in combination with a human recombinant laminin 521 (LN-521) to create a fully defined stem cell niche in 3D. A novel method to assemble silk blended with LN-521 together with human pluripotent stem cells (hPSC) is used to create centimeter-sized foams, which upon cultivation develop into 3D cell constructs supported by a microfibrillar network. After initial cell expansion, neural differentiation was induced to form a homogenous layer of continuous neuroectodermal tissue that allows further differentiation into neuronal subtypes. The silk-supported 3D cell constructs could then be detached from the bottom of the well and cultured as floating entities, where cells appeared in distinctive radial organization resembling early neural tube. This shows that the neural progenitors retain their cellular self-organization ability in the FN-silk/LN-521-supported 3D culture. Calcium imaging demonstrated spontaneous activity, which is important for the formation of neuronal networks. Together, the results show that hPSCs integrated into FN-silk/LN-521 foam develop into neural progenitors and that these stay viable during long-term differentiations. FN-silk/LN-521 also supports morphogenesis mimicking the human brain development and can serve as base for engineering of hPSC-derived neural tissue.
Collapse
Affiliation(s)
- Carolina Åstrand
- Dept. of Protein Science, School of Engineering Sciences in Chemistry, Biotechnology and Health, KTH-Royal Institute of Technology, SE-10691, Stockholm, Sweden.
| | | | | | | |
Collapse
|
54
|
Krüger M, Oosterhoff LA, van Wolferen ME, Schiele SA, Walther A, Geijsen N, De Laporte L, van der Laan LJW, Kock LM, Spee B. Cellulose Nanofibril Hydrogel Promotes Hepatic Differentiation of Human Liver Organoids. Adv Healthc Mater 2020; 9:e1901658. [PMID: 32090504 DOI: 10.1002/adhm.201901658] [Citation(s) in RCA: 52] [Impact Index Per Article: 13.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/20/2019] [Revised: 02/01/2020] [Indexed: 12/16/2022]
Abstract
To replicate functional liver tissue in vitro for drug testing or transplantation, 3D tissue engineering requires representative cell models as well as scaffolds that not only promote tissue production but also are applicable in a clinical setting. Recently, adult liver-derived liver organoids are found to be of much interest due to their genetic stability, expansion potential, and ability to differentiate toward a hepatocyte-like fate. The current standard for culturing these organoids is a basement membrane hydrogel like Matrigel (MG), which is derived from murine tumor material and apart from its variability and high costs, possesses an undefined composition and is therefore not clinically applicable. Here, a cellulose nanofibril (CNF) hydrogel is investigated with regard to its potential to serve as an alternative clinical grade scaffold to differentiate liver organoids. The results show that its mechanical properties are suitable for differentiation with overall, either equal or improved, functionality of the hepatocyte-like cells compared to MG. Therefore, and because of its defined and tunable chemical definition, the CNF hydrogel presents a viable alternative to MG for liver tissue engineering with the option for clinical use.
Collapse
Affiliation(s)
- Melanie Krüger
- Department of Clinical Sciences of Companion AnimalsFaculty of Veterinary MedicineUtrecht University Uppsalalaan 8 3584 CT Utrecht The Netherlands
- LifeTec Group BV Kennedyplein 10‐11 5611 ZS Eindhoven The Netherlands
| | - Loes A. Oosterhoff
- Department of Clinical Sciences of Companion AnimalsFaculty of Veterinary MedicineUtrecht University Uppsalalaan 8 3584 CT Utrecht The Netherlands
| | - Monique E. van Wolferen
- Department of Clinical Sciences of Companion AnimalsFaculty of Veterinary MedicineUtrecht University Uppsalalaan 8 3584 CT Utrecht The Netherlands
| | - Simon A. Schiele
- DWI – Leibniz‐Institut für Interaktive Materialien e.V.Advanced Materials for BiomedicineITMC – Institute of Technical and Macromolecular ChemistryRWTH University Aachen Forckenbeckstr. 50 52056 Aachen Germany
| | - Andreas Walther
- Albert‐Ludwigs‐Universität FreiburgInstitute for Macromolecular Chemistry Stefan‐Meier‐Strasse 3, Hermann Staudinger Building 79104 Freiburg Germany
| | - Niels Geijsen
- Department of Clinical Sciences of Companion AnimalsFaculty of Veterinary MedicineUtrecht University Uppsalalaan 8 3584 CT Utrecht The Netherlands
- Hubrecht Institute for Developmental Biology and Stem Cell ResearchUniversity Medical Center Utrecht Uppsalalaan 8 3584 CT Utrecht The Netherlands
| | - Laura De Laporte
- DWI – Leibniz‐Institut für Interaktive Materialien e.V.Advanced Materials for BiomedicineITMC – Institute of Technical and Macromolecular ChemistryRWTH University Aachen Forckenbeckstr. 50 52056 Aachen Germany
| | | | - Linda M. Kock
- LifeTec Group BV Kennedyplein 10‐11 5611 ZS Eindhoven The Netherlands
| | - Bart Spee
- Department of Clinical Sciences of Companion AnimalsFaculty of Veterinary MedicineUtrecht University Uppsalalaan 8 3584 CT Utrecht The Netherlands
| |
Collapse
|
56
|
Placone JK, Mahadik B, Fisher JP. Addressing present pitfalls in 3D printing for tissue engineering to enhance future potential. APL Bioeng 2020; 4:010901. [PMID: 32072121 PMCID: PMC7010521 DOI: 10.1063/1.5127860] [Citation(s) in RCA: 25] [Impact Index Per Article: 6.3] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/16/2019] [Accepted: 12/08/2019] [Indexed: 12/28/2022] Open
Abstract
Additive manufacturing in tissue engineering has significantly advanced in acceptance and use to address complex problems. However, there are still limitations to the technologies used and potential challenges that need to be addressed by the community. In this manuscript, we describe how the field can be advanced not only through the development of new materials and techniques but also through the standardization of characterization, which in turn may impact the translation potential of the field as it matures. Furthermore, we discuss how education and outreach could be modified to ensure end-users have a better grasp on the benefits and limitations of 3D printing to aid in their career development.
Collapse
|
57
|
Curvello R, Kerr G, Micati DJ, Chan WH, Raghuwanshi VS, Rosenbluh J, Abud HE, Garnier G. Engineered Plant-Based Nanocellulose Hydrogel for Small Intestinal Organoid Growth. ADVANCED SCIENCE (WEINHEIM, BADEN-WURTTEMBERG, GERMANY) 2020; 8:2002135. [PMID: 33437574 PMCID: PMC7788499 DOI: 10.1002/advs.202002135] [Citation(s) in RCA: 29] [Impact Index Per Article: 7.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/08/2020] [Revised: 10/12/2020] [Indexed: 05/27/2023]
Abstract
Organoids are three-dimensional self-renewing and organizing clusters of cells that recapitulate the behavior and functionality of developed organs. Referred to as "organs in a dish," organoids are invaluable biological models for disease modeling or drug screening. Currently, organoid culture commonly relies on an expensive and undefined tumor-derived reconstituted basal membrane which hinders its application in high-throughput screening, regenerative medicine, and diagnostics. Here, we introduce a novel engineered plant-based nanocellulose hydrogel is introduced as a well-defined and low-cost matrix that supports organoid growth. Gels containing 0.1% nanocellulose fibers (99.9% water) are ionically crosslinked and present mechanical properties similar to the standard animal-based matrix. The regulation of the osmotic pressure is performed by a salt-free strategy, offering conditions for cell survival and proliferation. Cellulose nanofibers are functionalized with fibronectin-derived adhesive sites to provide the required microenvironment for small intestinal organoid growth and budding. Comparative transcriptomic profiling reveals a good correlation with transcriptome-wide gene expression pattern between organoids cultured in both materials, while differences are observed in stem cells-specific marker genes. These hydrogels are tunable and can be combined with laminin-1 and supplemented with insulin-like growth factor (IGF-1) to optimize the culture conditions. Nanocellulose hydrogel emerges as a promising matrix for the growth of organoids.
Collapse
Affiliation(s)
- Rodrigo Curvello
- Bioresource Processing Research Institute of Australia (BioPRIA)Department of Chemical EngineeringMonash UniversityClaytonVictoria3800Australia
| | - Genevieve Kerr
- Department of Anatomy and Developmental Biology and Development and Stem Cells ProgramMonash Biomedicine Discovery InstituteClaytonVictoria3800Australia
| | - Diana J. Micati
- Department of Anatomy and Developmental Biology and Development and Stem Cells ProgramMonash Biomedicine Discovery InstituteClaytonVictoria3800Australia
| | - Wing Hei Chan
- Department of Anatomy and Developmental Biology and Development and Stem Cells ProgramMonash Biomedicine Discovery InstituteClaytonVictoria3800Australia
| | - Vikram S. Raghuwanshi
- Bioresource Processing Research Institute of Australia (BioPRIA)Department of Chemical EngineeringMonash UniversityClaytonVictoria3800Australia
| | - Joseph Rosenbluh
- Department of Biochemistry and Molecular BiologyMonash UniversityClaytonVictoria3800Australia
| | - Helen E. Abud
- Department of Anatomy and Developmental Biology and Development and Stem Cells ProgramMonash Biomedicine Discovery InstituteClaytonVictoria3800Australia
| | - Gil Garnier
- Bioresource Processing Research Institute of Australia (BioPRIA)Department of Chemical EngineeringMonash UniversityClaytonVictoria3800Australia
| |
Collapse
|